Drugs / Venlafaxine ER
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00083980 Comparator | Jun 2002 → Jun 2004 | generalized anxiety disorder | National Center for Complementary and Integrative Health (NCCIH) | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Venlafaxine ER | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00083980 ↗ |
| Known as | VEN | “This study will compare KAV, the drug venlafaxine-XR (VEN), and placebo for the treatment of GAD.” NCT00083980 ↗ |
| Known as | venlafaxine-XR | “This study will compare KAV, the drug venlafaxine-XR (VEN), and placebo for the treatment of GAD.” NCT00083980 ↗ |